Table 4 Yearly market share by prescription volume and costs of antineoplastic agents by region (2009-2012)
From: Geographic Variations and Time Trends in Cancer Treatments in Taiwan
Region | Year | Market share by prescription volume and Costs of targeted therapies | ||||||
|---|---|---|---|---|---|---|---|---|
Population | Number of prescription for TT | Number of prescription for all antineoplastic agents | Market share by prescription volume (%) | Cost of TT (US$) | Cost of all antineoplastic agents (US$) | Market share by cost (%) | ||
Northern | 2009 | 10,794,022 | 41,563 | 1,200,447 | 3.46 | 44,727,733 | 245,327,406 | 18.23 |
2010 | 10,852,146 | 53,085 | 1,352,126 | 3.93 | 64,066,867 | 298,340,256 | 21.47 | |
2011 | 10,919,415 | 74,409 | 1,539,869 | 4.83 | 80,098,867 | 335,228,190 | 23.89 | |
2012 | 10,991,480 | 107,447 | 1,681,041 | 6.39 | 108,328,729 | 369,543,105 | 29.31 | |
Midwestern | 2009 | 5,201,847 | 16,182 | 517,142 | 3.13 | 17,550,735 | 105,008,551 | 16.71 |
2010 | 5,199,849 | 22,116 | 587,463 | 3.76 | 25,919,867 | 130,844,276 | 19.81 | |
2011 | 5,203,796 | 28,424 | 641,058 | 4.43 | 31,768,038 | 148,131,812 | 21.45 | |
2012 | 5,215,948 | 41,136 | 691,949 | 5.94 | 45,052,173 | 168,569,414 | 26.73 | |
Southern | 2009 | 6,446,720 | 26,808 | 735,122 | 3.65 | 27,431,583 | 143,013,766 | 19.18 |
2010 | 6,433,342 | 33,836 | 834,331 | 4.06 | 37,988,591 | 178,074,087 | 21.33 | |
2011 | 6,422,584 | 45,262 | 904,722 | 5.00 | 48,387,511 | 201,906,589 | 23.97 | |
2012 | 6,422,531 | 65,905 | 983,272 | 6.70 | 66,284,539 | 223,610,507 | 29.64 | |
Eastern | 2009 | 573,461 | 1,255 | 52,193 | 2.40 | 1,872,532 | 9,729,754 | 19.25 |
2010 | 569,478 | 1,736 | 60,197 | 2.88 | 2,248,464 | 12,178,410 | 18.46 | |
2011 | 565,128 | 2,415 | 66,179 | 3.65 | 2,951,519 | 14,101,363 | 20.93 | |
2012 | 561,442 | 3,047 | 68,875 | 4.42 | 3,493,182 | 14,396,745 | 24.26 | |
Outer Islands | 2009 | 103,722 | 1 | 2,431 | 0.04 | 53 | 170,837 | 0.03 |
2010 | 107,308 | 0 | 3,261 | 0.00 | 0 | 316,458 | 0.00 | |
2011 | 113,989 | 1 | 3,654 | 0.03 | 649 | 387,676 | 0.17 | |
2012 | 124,421 | 26 | 4,539 | 0.57 | 17,180 | 481,335 | 3.57 | |